Cargando…

Recombinant VLPs empower RBM peptides showing no immunogenicity in native SARS-COV-2 protein to elicit a robust neutralizing antibody response

New SARS-COV-2 vaccine strategies are still urgently needed, especially for emerging virus mutations and variants. In this study, we focused on analyzing the antigenicity and vaccine potency of linear peptide epitopes located in receptor binding motif (RBM) of spike (S) protein. Nine 12 to 16-mer ov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, Qiong, Yang, Ying, Yang, Mengli, Bai, Hongmei, Sun, Wenjia, Yang, Xu, Huang, Weiwei, Li, Duo, Ma, Yanbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800570/ https://www.ncbi.nlm.nih.gov/pubmed/35104670 http://dx.doi.org/10.1016/j.nano.2022.102527

Ejemplares similares

Vaccination with VLPs Presenting a Linear Neutralizing Domain of S. aureus Hla Elicits Protective Immunity
por: Joyner, Jason A., et al.
Publicado: (2020)

Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)
por: Naupu, Paulina N., et al.
Publicado: (2020)

SARS-CoV-2 RBD dimers elicit response comparable to VLPs in mice
por: Love, J., et al.
Publicado: (2023)

Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii
por: Huang, Weiwei, et al.
Publicado: (2016)

High immunogenicity of virus-like particles (VLPs) decorated with Aeromonas salmonicida VapA antigen in rainbow trout
por: Yang, Jeong In, et al.
Publicado: (2023)

AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate
por: Liu, Xuelan, et al.
Publicado: (2021)

Structure-Based Design of Porcine Circovirus Type 2 Chimeric VLPs (cVLPs) Displays Foreign Peptides on the Capsid Surface
por: Wang, Dongliang, et al.
Publicado: (2018)

CuMV VLPs Containing the RBM from SARS-CoV-2 Spike Protein Drive Dendritic Cell Activation and Th1 Polarization
por: Sebastião, Ana Isabel, et al.
Publicado: (2023)

114 VLPs and particle vaccines
por: Buonaguro, Luigi
Publicado: (2014)

RNA: packaged and protected by VLPs
por: Fang, Po-Yu, et al.
Publicado: (2018)

P. falciparum and P. vivax Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage Infections
por: Whitacre, David C., et al.
Publicado: (2015)

Functional RNAs: combined assembly and packaging in VLPs
por: Fang, Po-Yu, et al.
Publicado: (2017)

Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor
por: Wang, Shijie, et al.
Publicado: (2017)

Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs
por: Feng, Hao, et al.
Publicado: (2015)

Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform—Analysis of Production and Immunogenicity
por: Ortiz, Raquel, et al.
Publicado: (2023)

Packaging of actin into Ebola virus VLPs
por: Han, Ziying, et al.
Publicado: (2005)

Self-Assembled Nanofibers Elicit Potent HPV16 E7-Specific Cellular Immunity And Abolish Established TC-1 Graft Tumor
por: Li, Sijin, et al.
Publicado: (2019)

Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection
por: Huang, Weiwei, et al.
Publicado: (2016)

Native envelope-based immunogens derived from critical timepoints in the development of breadth elicit rapid neutralizing antibodies in rabbits
por: Malherbe, DC, et al.
Publicado: (2012)

Mixed Bacteriophage MS2-L2 VLPs Elicit Long-Lasting Protective Antibodies against HPV Pseudovirus 51
por: Yadav, Rashi, et al.
Publicado: (2021)

Two RSV Platforms for G, F, or G+F Proteins VLPs
por: Ha, Binh, et al.
Publicado: (2020)

Robust RBM3 and β-klotho expression in developing neurons in the human brain
por: Jackson, Travis C, et al.
Publicado: (2019)

Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs
por: Zepeda-Cervantes, Jesús, et al.
Publicado: (2020)

Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern
por: Almanza, Gonzalo, et al.
Publicado: (2022)

Polymerized porin as a novel delivery platform for coronavirus vaccine
por: Yang, Zhongqian, et al.
Publicado: (2022)

Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant
por: Waerlop, Gwenn, et al.
Publicado: (2023)

Abrogation of contaminating RNA activity in HIV-1 Gag VLPs
por: Valley-Omar, Ziyaad, et al.
Publicado: (2011)

Production of Brazilian human norovirus VLPs and comparison of purification methods
por: Lamounier, Thais Alves da Costa, et al.
Publicado: (2015)

Construction of HER2-Specific HIV-1-Based VLPs
por: Martins, Sofia A., et al.
Publicado: (2022)

Zika virus-like particles (VLPs) produced in insect cells
por: de Mello, Renata Gois, et al.
Publicado: (2023)

Rbm24a and Rbm24b Are Required for Normal Somitogenesis
por: Maragh, Samantha, et al.
Publicado: (2014)

Autoregulation of RBM10 and cross-regulation of RBM10/RBM5 via alternative splicing-coupled nonsense-mediated decay
por: Sun, Yue, et al.
Publicado: (2017)

Dissolving Microneedles Loaded with Nanoparticle Formulation of Respiratory Syncytial Virus Fusion Protein Virus-like Particles (F-VLPs) Elicits Cellular and Humoral Immune Responses
por: Menon, Ipshita, et al.
Publicado: (2023)

Assembly of HCV E1 and E2 glycoproteins into coronavirus VLPs
por: Jourdan, N., et al.
Publicado: (2006)

RBM6-RBM5 transcription-induced chimeras are differentially expressed in tumours
por: Wang, Ke, et al.
Publicado: (2007)

Immunogenicity of Wild Type and Mutant Hepatitis B Surface Antigen Virus-like Particles (VLPs) in Mice with Pre-Existing Immunity against the Wild Type Vector
por: Kingston, Natalie J., et al.
Publicado: (2023)

Star nanoparticles delivering HIV-1 peptide minimal immunogens elicit near-native envelope antibody responses in nonhuman primates
por: Francica, Joseph R., et al.
Publicado: (2019)

Exploiting immunostimulatory mechanisms of immunogenic cell death to develop membrane-encapsulated nanoparticles as a potent tumor vaccine
por: Liu, Qingwen, et al.
Publicado: (2023)

Vibrio cholerae biofilm scaffolding protein RbmA shows an intrinsic, phosphate‐dependent autoproteolysis activity
por: Maestre‐Reyna, Manuel, et al.
Publicado: (2020)

The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV
por: Cullen, Lori M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i95chnt7kin1n2jujdtpngt7j9